Evolent Health, Inc. (NYSE:EVH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price objective among […]
Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently have a buy rating on the technology company’s stock. A number of other equities analysts have also issued reports on the company. Oppenheimer assumed […]
Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the technology company’s stock. Several other analysts have also commented on EVH. William Blair reiterated an outperform rating on shares […]
Evolent Health (NYSE:EVH – Free Report) had its target price trimmed by Canaccord Genuity Group from $47.00 to $45.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the technology company’s stock. A number of other equities analysts also recently weighed in on EVH. […]
Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]